GRCL
Gracell Biotechnologies Inc
$10.25
Earnings Summary
Revenue | $0Mn |
Net Profits | $-67.63Mn |
Net Profit Margins | -Inf% |
Highlights
Gracell Biotechnologies Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2023. On a quarterly growth basis, Gracell Biotechnologies Inc has generated NaN% jump in its revenue since last 3-months.
Gracell Biotechnologies Inc’s net profit jumped 60.73% since last year same period to $-67.63Mn in the Q3 2023. On a quarterly growth basis, Gracell Biotechnologies Inc has generated 53.98% jump in its net profits since last 3-months.
Gracell Biotechnologies Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2023. On a quarterly growth basis, Gracell Biotechnologies Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Gracell Biotechnologies Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.09 |
EPS Estimate Current Year | -0.09 |
Highlights
Gracell Biotechnologies Inc’s earning per share (EPS) estimates for the current quarter stand at -0.09 - a 34.64% jump from last quarter’s estimates.
Gracell Biotechnologies Inc’s earning per share (EPS) estimates for the current year stand at -0.09.
Key Ratios
Key ratios of the Gracell Biotechnologies Inc post its Q3 2023 earnings
Earning Per Share (EPS) | -0.1 |
Highlights
Gracell Biotechnologies Inc’s earning per share (EPS) jumped 71.43% since last year same period to -0.1 in the Q3 2023. This indicates that the Gracell Biotechnologies Inc has generated 71.43% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-04-25 | -0.39 | -0.35 | 10.26% |
2023-08-14 | -0.4 | -0.3 | 25% |
2023-09-30 | -0.2 | -0.1 | 50% |
₹0 US Stocks a/c Opening Fee